drugset / Trial / NCT00962039
Anxiety and Recurrent Abdominal Pain in Children
Phase 2/3
Completed
81 enrolled
John V. Campo, M.D.
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study aims to determine whether citalopram is a useful, well-tolerated, and safe treatment for children and adolescents ages 7 to 18 years with functional abdominal pain. The study hypothesis is that citalopram will be better than placebo in producing clinical improvement and reductions in abdominal pain. It is also hypothesized that citalopram and placebo will not differ in terms of safety and tolerability.
Timeline
- Start
- 2004-07
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Citalopram | Small molecule | 20 mg | — |
| Subject | Citalopram | Small molecule | 40 mg | — |